{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:42:31Z","timestamp":1790944951570,"version":"4.1.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.phrs.2010.12.008","type":"journal-article","created":{"date-parts":[[2010,12,28]],"date-time":"2010-12-28T09:43:12Z","timestamp":1293529392000},"page":"525-531","source":"Crossref","is-referenced-by-count":42,"title":["Endothelin receptor antagonists: Potential in Alzheimer's disease"],"prefix":"10.1016","volume":"63","author":[{"given":"Jennifer","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2010.12.008_bib0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(02)09420-5","article-title":"Alzheimer's disease","volume":"360","author":"Burns","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2010.12.008_bib0010","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Alzheimer's disease I. Global prevalence of dementia: a delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2010.12.008_bib0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of alzheimer's disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.phrs.2010.12.008_bib0020","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1073\/pnas.082107399","article-title":"Imaging the progression of alzheimer pathology through the brain","volume":"99","author":"Smith","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.phrs.2010.12.008_bib0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF00698298","article-title":"Cortical atrophy in senile dementia of the alzheimer type is mainly due to a decrease in cortical length","volume":"66","author":"Duyckaerts","year":"1985","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.phrs.2010.12.008_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neurobiolaging.2006.09.013","article-title":"Automated cortical thickness measurements from mri can accurately separate alzheimer's patients from normal elderly controls","volume":"29","author":"Lerch","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.phrs.2010.12.008_bib0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.410100209","article-title":"Some morphometric aspects of the brain in senile dementia of the alzheimer type","volume":"10","author":"Terry","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0040","first-page":"909","article-title":"Neurofibrillary pathology \u2013 correlation with hippocampal formation atrophy in alzheimer disease","volume":"17","author":"Bobinski","year":"1996","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.phrs.2010.12.008_bib0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/PL00014174","article-title":"In vivo pet imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in alzheimer's disease","volume":"249","author":"Rapoport","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0050","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in alzheimers-disease \u2013 synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","article-title":"Altered expression of synaptic proteins occurs early during progression of alzheimer's disease","volume":"56","author":"Masliah","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2010.12.008_bib0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-3940(94)90121-X","article-title":"Synaptic and neuritic alterations during the progression of alzheimer's disease","volume":"174","author":"Masliah","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.phrs.2010.12.008_bib0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.phrs.2010.12.008_bib0070","first-page":"1","article-title":"Contribution of cerebral amyloid angiopathy to alzheimer's disease","volume":"75","author":"Love","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.phrs.2010.12.008_bib0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1196\/annals.1379.023","article-title":"Fibrillar and oligomeric \u03b2-amyloid as distinct local biomarkers for alzheimer's disease","volume":"1097","author":"Montalto","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0080","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.38.11.1682","article-title":"Clinicopathologic studies in dementia \u2013 nondemented subjects with pathologically confirmed alzheimers-disease","volume":"38","author":"Crystal","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2010.12.008_bib0085","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.neurobiolaging.2005.04.017","article-title":"Common mechanisms of amyloid oligomer pathogenesis in degenerative disease","volume":"27","author":"Glabe","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.phrs.2010.12.008_bib0090","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-\u03b2 peptides differentially affect neuronal viability","volume":"277","author":"Dahlgren","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0095","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2010.12.008_bib0100","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","article-title":"Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers","volume":"572","author":"Townsend","year":"2006","journal-title":"J Physiol-Lond"},{"key":"10.1016\/j.phrs.2010.12.008_bib0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-\u03b2 protein dimers isolated directly from alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.phrs.2010.12.008_bib0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneumeth.2008.09.002","article-title":"Characterisation of two antibodies to oligomeric a\u03b2 and their use in elisas on human brain tissue homogenates","volume":"176","author":"van Helmond","year":"2009","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.phrs.2010.12.008_bib0115","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid-\u03b2 peptide concentration as a predictor of synaptic change in alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0120","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","article-title":"Water-soluble a\u03b2 (n-40, n-42) oligomers in normal and alzheimer disease brains","volume":"271","author":"Kuo","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7085","article-title":"The levels of soluble versus insoluble brain a\u03b2 distinguish alzheimer's disease from normal and pathologic aging","volume":"158","author":"Wang","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of a\u03b2 amyloid as a determinant of severity of neurodegeneration in alzheimer's disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0135","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer's disease-affected brain: presence of oligomeric a\u03b2 ligands (addls) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.phrs.2010.12.008_bib0140","doi-asserted-by":"crossref","first-page":"34186","DOI":"10.1074\/jbc.M501694200","article-title":"B-amyloid is different in normal aging and in alzheimer disease","volume":"280","author":"Piccini","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1113\/jphysiol.2006.111203","article-title":"Physiological roles for amyloid beta peptides","volume":"575","author":"Pearson","year":"2006","journal-title":"J Physiol-Lond"},{"key":"10.1016\/j.phrs.2010.12.008_bib0150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2010.12.008_bib0155","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1073\/pnas.0205689101","article-title":"Amyloid \u03b2 peptide load is correlated with increased \u03b2-secretase activity in sporadic alzheimer's disease patients","volume":"101","author":"Li","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.phrs.2010.12.008_bib0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nm0103-3","article-title":"Elevated \u03b2-secretase expression and enzymatic activity detected in sporadic alzheimer disease","volume":"9","author":"Yang","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.phrs.2010.12.008_bib0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0006-291X(02)02635-9","article-title":"A- and \u03b2-secretase: profound changes in alzheimer's disease","volume":"299","author":"Tyler","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.phrs.2010.12.008_bib0170","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1523\/JNEUROSCI.4396-06.2007","article-title":"B-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for alzheimer's disease pathogenesis","volume":"27","author":"Zhao","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2990.2003.00424.x","article-title":"Capillary and arterial cerebral amyloid angiopathy in alzheimer's disease: defining the perivascular route for the elimination of amyloid \u03b2 from the human brain","volume":"29","author":"Preston","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0180","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9440(10)65616-7","article-title":"Cerebral amyloid angiopathy \u2013 amyloid-\u03b2 accumulates in putative interstitial fluid drainage pathways in alzheimer's disease","volume":"153","author":"Weller","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0185","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","article-title":"B-amyloid efflux mediated by p-glycoprotein","volume":"76","author":"Lam","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0190","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of alzheimer's amyloid-\u03b21\u201340 peptide from brain by ldl receptor-related protein-1 at the blood\u2013brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.phrs.2010.12.008_bib0195","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1042\/BST20051101","article-title":"A\u03b2-degrading enzymes: modulators of alzheimer's disease pathogenesis and targets for therapeutic intervention","volume":"33","author":"Eckman","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.phrs.2010.12.008_bib0200","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1073\/pnas.0710823105","article-title":"Enhanced clearance of a\u03b2 in brain by sustaining the plasmin proteolysis cascade","volume":"105","author":"Jacobsen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.phrs.2010.12.008_bib0205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"Apoe promotes the proteolytic degradation of a\u03b2","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2010.12.008_bib0210","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1152\/japplphysiol.00260.2002","article-title":"Syncope, cerebral perfusion, and oxygenation","volume":"94","author":"van Lieshout","year":"2003","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/HYPERTENSIONAHA.106.079442","article-title":"Cerebrovascular function in pregnancy and eclampsia","volume":"50","author":"Cipolla","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2010.12.008_bib0220","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tips.2007.05.006","article-title":"New technologies for dissecting the arteriolar myogenic response","volume":"28","author":"Hill","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0225","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1113\/jphysiol.1902.sp000911","article-title":"On the local reactions of the arterial wall to changes of internal pressure","volume":"28","author":"Bayliss","year":"1902","journal-title":"J Physiol-Lond"},{"key":"10.1016\/j.phrs.2010.12.008_bib0230","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nn2003","article-title":"Glial regulation of the cerebral microvasculature","volume":"10","author":"Iadecola","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0235","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/jcbfm.1993.113","article-title":"Localized dynamic changes in cortical blood-flow with whisker stimulation corresponds to matched vascular and neuronal architecture of rat barrels","volume":"13","author":"Cox","year":"1993","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.phrs.2010.12.008_bib0240","first-page":"H133","article-title":"Effect of sciatic-nerve stimulation on pial arterioles in rats","volume":"254","author":"Ngai","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0245","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00004647-200001000-00025","article-title":"Early temporal characteristics of cerebral blood flow and deoxyhemoglobin changes during somatosensory stimulation","volume":"20","author":"Silva","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.phrs.2010.12.008_bib0250","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in alzheimer's disease","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0255","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0166-2236(03)00227-3","article-title":"Interneuron diversity series: rhythm and mood in perisomatic inhibition","volume":"26","author":"Freund","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0260","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1152\/jn.1996.75.2.940","article-title":"Neural mechanisms of blood flow regulation during synaptic activity in cerebellar cortex","volume":"75","author":"Iadecola","year":"1996","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0265","doi-asserted-by":"crossref","first-page":"R1760","DOI":"10.1152\/ajpregu.1999.277.6.R1760","article-title":"Nitric oxide is the predominant mediator of cerebellar hyperemia during somatosensory activation in rats","volume":"277","author":"Yang","year":"1999","journal-title":"Am J Physiol-Regul Integr Comp Physiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0270","doi-asserted-by":"crossref","first-page":"H298","DOI":"10.1152\/ajpheart.00043.2003","article-title":"Attenuation of activity-induced increases in cerebellar blood flow in mice lacking neuronal nitric oxide synthase","volume":"285","author":"Yang","year":"2003","journal-title":"Am J Physiol-Heart Circul Physiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0275","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1523\/JNEUROSCI.20-18-06968.2000","article-title":"Stellate neurons mediate functional hyperemia in the cerebellar molecular layer","volume":"20","author":"Yang","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0280","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.20516","article-title":"Is alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion?","volume":"57","author":"de la Torre","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0285","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0733-8619(05)70231-0","article-title":"Neuroimaging in dementia","volume":"18","author":"Jagust","year":"2000","journal-title":"Neurol Clin"},{"key":"10.1016\/j.phrs.2010.12.008_bib0290","first-page":"761","article-title":"Application of i-123 labeled isopropylamphetamine imaging to the study of dementia","volume":"27","author":"Sharp","year":"1986","journal-title":"J Nucl Med"},{"key":"10.1016\/j.phrs.2010.12.008_bib0295","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archneur.1987.00520150014011","article-title":"The diagnosis of dementia with single photon-emission computed-tomography","volume":"44","author":"Jagust","year":"1987","journal-title":"Arch Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0300","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00006231-200503000-00003","article-title":"Emission tomography in dementia","volume":"26","author":"Pakrasi","year":"2005","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.phrs.2010.12.008_bib0305","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jalz.2009.04.1233","article-title":"Cerebral blood flow in ischemic vascular dementia and alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging","volume":"5","author":"Schuff","year":"2009","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.phrs.2010.12.008_bib0310","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1259\/bjr\/33117326","article-title":"Role of imaging techniques in the diagnosis of dementia","volume":"80","author":"O\u2019Brien","year":"2007","journal-title":"Br J Radiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002093-199040100-00002","article-title":"Assessing utility of single photon emission computed tomography spect scan in alzheimer disease correlation with cognitive severity","volume":"4","author":"Dekosky","year":"1990","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.phrs.2010.12.008_bib0320","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.66.2.228","article-title":"Tc-99m hmpao spect in the evaluation of alzheimer's disease: correlation between neuropsychiatric evaluation and cbf images","volume":"66","author":"Imran","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.phrs.2010.12.008_bib0325","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jocn.2003.02.013","article-title":"The relationship between cerebral blood flow and cognitive function in patients with brain insult of various etiology","volume":"11","author":"Shiraishi","year":"2004","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0330","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","article-title":"The age-dependent relation of blood pressure to cognitive function and dementia","volume":"4","author":"Qiu","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0335","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1179\/016164106X130506","article-title":"Update on hypertension and alzheimer's disease","volume":"28","author":"Skoog","year":"2006","journal-title":"Neurol Res"},{"key":"10.1016\/j.phrs.2010.12.008_bib0340","first-page":"208","article-title":"Hypertension and the rate of cognitive decline in patients with dementia of the alzheimer type","volume":"18","author":"Bellew","year":"2004","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.phrs.2010.12.008_bib0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0197-4580(00)00106-8","article-title":"Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the haas","volume":"21","author":"Petrovitch","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.phrs.2010.12.008_bib0350","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0022-510X(95)00105-B","article-title":"Increased incidence of neurofibrillary tangles (nft) in nondemented individuals with hypertension","volume":"131","author":"Sparks","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.HYP.0000132475.32317.bb","article-title":"Midlife blood pressure and the risk of hippocampal atrophy \u2013 the honolulu asia aging study","volume":"44","author":"Korf","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2010.12.008_bib0360","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/01.WNL.0000149641.55751.2E","article-title":"Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe","volume":"64","author":"den Heijer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2010.12.008_bib0365","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"Br Med J"},{"key":"10.1016\/j.phrs.2010.12.008_bib0370","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/msj.20155","article-title":"Role of vascular risk factors and vascular dysfunction in alzheimer's disease","volume":"77","author":"Dickstein","year":"2010","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.phrs.2010.12.008_bib0375","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia - the rotterdam study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2010.12.008_bib0380","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.277.10.813","article-title":"Brain infarction and the clinical expression of alzheimer disease \u2013 the nun study","volume":"277","author":"Snowdon","year":"1997","journal-title":"JAMA-J Am Med Assoc"},{"key":"10.1016\/j.phrs.2010.12.008_bib0385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.20493","article-title":"Cerebral hypoperfusion and clinical onset of dementia: the rotterdam study","volume":"57","author":"Ruitenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0390","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00294173","article-title":"Pathological alterations of the cerebral microvasculature in alzheimers-disease and related dementing disorders","volume":"87","author":"Buee","year":"1994","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.phrs.2010.12.008_bib0395","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5715","article-title":"Sod1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein","volume":"2","author":"Iadecola","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0400","doi-asserted-by":"crossref","first-page":"H315","DOI":"10.1152\/ajpheart.00022.2002","article-title":"Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein","volume":"283","author":"Niwa","year":"2002","journal-title":"Am J Physiol-Heart Circul Physiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0405","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/nbdi.2001.0460","article-title":"Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein","volume":"9","author":"Niwa","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.phrs.2010.12.008_bib0410","first-page":"125","article-title":"Blood flow metabolism couple in brain","volume":"53","author":"Reivich","year":"1974","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"10.1016\/j.phrs.2010.12.008_bib0415","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","article-title":"Deoxyglucose-c-14 method for measurement of local cerebral glucose-utilization \u2013 theory, procedure, and normal values in conscious and anesthetized albino-rat","volume":"28","author":"Sokoloff","year":"1977","journal-title":"J Neurochem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0420","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","article-title":"Mild cognitive impairment \u2013 can fdg-pet predict who is to rapidly convert to alzheimer's disease?","volume":"60","author":"Chetelat","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2010.12.008_bib0425","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.20799","article-title":"Brain imaging evidence of preclinical alzheimer's disease in normal aging","volume":"59","author":"Jagust","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0430","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","article-title":"Positron emission tomography in evaluation of dementia \u2013 regional brain metabolism and long-term outcome","volume":"286","author":"Silverman","year":"2001","journal-title":"JAMA-J Am Med Assoc"},{"key":"10.1016\/j.phrs.2010.12.008_bib0435","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0440","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02988444","article-title":"Pet studies in dementia","volume":"17","author":"Herholz","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.phrs.2010.12.008_bib0445","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/01.wnl.0000269790.05105.16","article-title":"What does fluorodeoxyglucose pet imaging add to a clinical diagnosis of dementia?","volume":"69","author":"Jagust","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2010.12.008_bib0450","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, a\u03b2 elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.phrs.2010.12.008_bib0455","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0896-6273(95)90107-8","article-title":"Age-related cns disorder and early death in transgenic fvb\/n mice overexpressing alzheimer amyloid precursor proteins","volume":"15","author":"Hsiao","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2010.12.008_bib0460","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.neuropharm.2009.01.006","article-title":"Reduction of the cerebrovascular volume in a transgenic mouse model of alzheimer's disease","volume":"56","author":"Bourasset","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2010.12.008_bib0465","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/exnr.1997.6743","article-title":"Characteristics of the in vitro vasoactivity of \u03b2-amyloid peptides","volume":"150","author":"Crawford","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0470","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1179\/016164101101198758","article-title":"Physiological levels of \u03b2-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production","volume":"23","author":"Price","year":"2001","journal-title":"Neurol Res"},{"key":"10.1016\/j.phrs.2010.12.008_bib0475","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/01616412.1997.11740853","article-title":"B-amyloid induces cerebrovascular endothelial dysfunction in the rat brain","volume":"19","author":"Price","year":"1997","journal-title":"Neurol Res"},{"key":"10.1016\/j.phrs.2010.12.008_bib0480","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00004647-200012000-00005","article-title":"Exogenous a\u03b21\u201340 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice","volume":"20","author":"Niwa","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.phrs.2010.12.008_bib0485","doi-asserted-by":"crossref","first-page":"H2417","DOI":"10.1152\/ajpheart.2001.281.6.H2417","article-title":"A\u03b2-peptides enhance vasoconstriction in cerebral circulation","volume":"281","author":"Niwa","year":"2001","journal-title":"Am J Physiol-Heart Circul Physiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0490","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/380168a0","article-title":"B-amyloid-mediated vasoactivity and vascular endothelial damage","volume":"380","author":"Thomas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2010.12.008_bib0495","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/00001756-199704140-00014","article-title":"Cerebrovascular endothelial dysfunction mediated by \u03b2-amyloid","volume":"8","author":"Thomas","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2010.12.008_bib0500","doi-asserted-by":"crossref","first-page":"48135","DOI":"10.1074\/jbc.M407358200","article-title":"Mechanisms of soluble \u03b2-amyloid impairment of endothelial function","volume":"279","author":"Gentile","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0505","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuroscience.2008.04.021","article-title":"Non-invasive characterization of \u03b2-amyloid(1\u201340) vasoactivity by functional magnetic resonance imaging in mice","volume":"155","author":"Luo","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2010.12.008_bib0510","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.phrs.2009.09.004","article-title":"Long-term incubation with \u03b2-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery","volume":"61","author":"Chisari","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.phrs.2010.12.008_bib0515","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1326-5-15","article-title":"Soluble amyloid-\u03b2, effect on cerebral arteriolar regulation and vascular cells","volume":"5","author":"Dietrich","year":"2010","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.phrs.2010.12.008_bib0520","first-page":"H822","article-title":"Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor","volume":"250","author":"Rubanyi","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0525","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/exnr.1998.6828","article-title":"Role of peroxynitrite in the vasoactive and cytotoxic effects of alzheimer's \u03b2-amyloid(1\u201340) peptide","volume":"152","author":"Paris","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0530","first-page":"65","article-title":"Proinflammatory and vasoactive effects of a beta in the cerebrovasculature","volume":"977","author":"Townsend","year":"2002","journal-title":"Alzheimer's Dis: Vasc Etiol Pathol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0535","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0197-4580(00)82162-4","article-title":"Soluble \u03b2-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway","volume":"21","author":"Paris","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.phrs.2010.12.008_bib0540","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1179\/016164103101201940","article-title":"Vasoactive effects of a\u03b2 in isolated human cerebrovessels and in a transgenic mouse model of alzheimer's disease: role of inflammation","volume":"25","author":"Paris","year":"2003","journal-title":"Neurol Res"},{"key":"10.1016\/j.phrs.2010.12.008_bib0545","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2990.2010.01084.x","article-title":"Endothelin-converting enzyme-1 in alzheimer's disease and vascular dementia","volume":"36","author":"Palmer","year":"2010","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0550","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2353\/ajpath.2009.081054","article-title":"Endothelin-converting enzyme-2 is increased in alzheimer's disease and up-regulated by a\u03b2","volume":"175","author":"Palmer","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0555","doi-asserted-by":"crossref","first-page":"15262","DOI":"10.1074\/jbc.270.25.15262","article-title":"Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic ph optimum","volume":"270","author":"Emoto","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0560","doi-asserted-by":"crossref","first-page":"24540","DOI":"10.1074\/jbc.M007579200","article-title":"Degradation of the alzheimer's amyloid-\u03b2 peptide by endothelin-converting enzyme","volume":"276","author":"Eckman","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0565","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1172\/JCI7447","article-title":"Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development","volume":"105","author":"Yanagisawa","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.phrs.2010.12.008_bib0570","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1074\/jbc.C200642200","article-title":"Alzheimer's disease \u03b2-amyloid peptide is increased in mice deficient in endothelin-converting enzyme","volume":"278","author":"Eckman","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0575","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1601-183X.2007.00365.x","article-title":"Animals lacking endothelin-converting enzyme-2 are deficient in learning and memory","volume":"7","author":"Rodriguiz","year":"2008","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.phrs.2010.12.008_bib0580","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0278-5846(95)00031-P","article-title":"Endothelin-1-like immunoreactivity in cerebral-cortex of alzheimer-type dementia","volume":"19","author":"Minami","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.phrs.2010.12.008_bib0585","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"Rage mediates amyloid-\u03b2 peptide transport across the blood\u2013brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat Med"},{"issue":"suppl 1","key":"10.1016\/j.phrs.2010.12.008_bib0590","first-page":"18","article-title":"A\u03b2 induces endothelin-1 production by sh-sy5y neuroblastoma cells","volume":"20","author":"Palmer","year":"2010","journal-title":"Brain Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2010.12.008_bib0595","first-page":"34","article-title":"Et-1 is elevated in the brain in ad and its neuronal production and release are upregulated by a\u03b21\u201342","volume":"37","author":"Palmer","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0600","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/157016105774329381","article-title":"Localisation of endothelin-1 and its receptors in vascular tissue as seen at the electron microscopic level","volume":"3","author":"Loesch","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0605","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000025712","article-title":"Neural endothelin in hypertension: increased expression in ganglia and nerves to cerebral arteries of the spontaneously hypertensive rat","volume":"37","author":"Milner","year":"2000","journal-title":"J Vasc Res"},{"key":"10.1016\/j.phrs.2010.12.008_bib0610","first-page":"163","article-title":"Angiotensin-converting enzyme levels and activity in alzheimer's disease: differences in brain and csf ace and association with ace1 genotypes","volume":"1","author":"Miners","year":"2009","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.phrs.2010.12.008_bib0615","doi-asserted-by":"crossref","first-page":"31914","DOI":"10.1074\/jbc.M109.011437","article-title":"A\u03b242-to-a\u03b240-and angiotensin-converting activities in different domains of angiotensin-converting enzyme","volume":"284","author":"Zou","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0620","doi-asserted-by":"crossref","first-page":"37644","DOI":"10.1074\/jbc.M508460200","article-title":"Amyloid \u03b2-protein is degraded by cellular angiotensin-converting enzyme (ace) and elevated by an ace inhibitor","volume":"280","author":"Hemming","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0625","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tins.2009.07.006","article-title":"Angiotensins in alzheimer's disease \u2013 friend or foe?","volume":"32","author":"Kehoe","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0630","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S1041610203008688","article-title":"A clinical overview of cholinesterase inhibitors in alzheimer's disease","volume":"14","author":"Farlow","year":"2002","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.phrs.2010.12.008_bib0635","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00019442-200303000-00004","article-title":"Use of cholinesterase inhibitors in clinical practice \u2013 evidence-based recommendations","volume":"11","author":"Cummings","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.phrs.2010.12.008_bib0640","series-title":"Cochrane Database of Systematic Reviews","article-title":"Cholinesterase inhibitors for alzheimer's disease","author":"Birks","year":"2006"},{"key":"10.1016\/j.phrs.2010.12.008_bib0645","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1177\/0269881106068299","article-title":"Clinical practice with anti-dementia drugs: a consensus statement from british association for psychopharmacology","volume":"20","author":"Burns","year":"2006","journal-title":"J Psychopharmacol (Oxf)"},{"key":"10.1016\/j.phrs.2010.12.008_bib0650","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1586\/14737175.4.5.799","article-title":"Utilizing combination therapy in the treatment of alzheimer's disease","volume":"4","author":"Farlow","year":"2004","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.phrs.2010.12.008_bib0655","series-title":"Cochrane Database of Systematic Reviews","article-title":"Memantine for dementia","author":"McShane","year":"2006"},{"key":"10.1016\/j.phrs.2010.12.008_bib0660","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000122962","article-title":"Treatment options in alzheimer's disease: maximizing benefit, managing expectations","volume":"25","author":"Farlow","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.phrs.2010.12.008_bib0665","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/brain\/awl266","article-title":"Enhanced brain activity may precede the diagnosis of alzheimer's disease by 30 years","volume":"129","author":"Mondadori","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2010.12.008_bib0670","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer ii entorhinal cortex neurons occurs in very mild alzheimer's disease","volume":"16","author":"GomezIsla","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0675","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1212\/WNL.46.3.707","article-title":"Cerebral amyloid deposition and diffuse plaques in \u201cnormal\u201d aging: evidence for presymptomatic and very mild alzheimer's disease","volume":"46","author":"Morris","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2010.12.008_bib0680","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","article-title":"Early a\u03b2 accumulation and progressive synaptic loss, gliosis, and tangle formation in ad brain","volume":"62","author":"Ingelsson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2010.12.008_bib0685","first-page":"120","article-title":"Neuropathology after active a\u03b242 immunotherapy: implications for alzheimer's disease pathogenesis","author":"Boche","year":"2010","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.phrs.2010.12.008_bib0690","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of a\u03b242 immunisation in alzheimer's disease: follow-up of a randomised, placebo-controlled phase i trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2010.12.008_bib0695","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.21223","article-title":"B-amyloid burden is not associated with rates of brain atrophy","volume":"63","author":"Josephs","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0700","first-page":"9999","article-title":"Higher soluble amyloid-\u03b2 concentration in frontal cortex of young adults than in normal elderly or alzheimer's disease","author":"van Helmond","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0705","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.arr.2010.04.002","article-title":"Vascular risk factor detection and control may prevent alzheimer's disease","volume":"9","author":"de la Torre","year":"2010","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.phrs.2010.12.008_bib0710","doi-asserted-by":"crossref","first-page":"18727","DOI":"10.1073\/pnas.0606298103","article-title":"Hypoxia facilitates alzheimer's disease pathogenesis by up-regulating bace1 gene expression","volume":"103","author":"Sun","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.phrs.2010.12.008_bib0715","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1074\/jbc.M608856200","article-title":"Hypoxia-inducible factor 1 \u03b1 (hif-1 \u03b1)-mediated hypoxia increases bace1 expression and \u03b2-amyloid generation","volume":"282","author":"Zhang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.12.008_bib0720","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0306-4522(98)00659-9","article-title":"Cerebral hypoperfusion yields capillary damage in the hippocampal ca1 area that correlates with spatial memory impairment","volume":"91","author":"De Jong","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2010.12.008_bib0725","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1097\/00002093-200307004-00004","article-title":"Early intervention is key to successful management of alzheimer disease","volume":"17","author":"DeKosky","year":"2003","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.phrs.2010.12.008_bib0730","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1602\/neurorx.1.2.206","article-title":"Molecular neuroimaging in alzheimer's disease","volume":"1","author":"Jagust","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.phrs.2010.12.008_bib0735","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1139\/Y08-059","article-title":"Yanagisawa M. Endothelin: 20 years from discovery to therapy","volume":"86","author":"Barton","year":"2008","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0740","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1161\/01.CIR.98.21.2235","article-title":"Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease","volume":"98","author":"Wenzel","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2010.12.008_bib0745","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MNH.0b013e328335f91f","article-title":"Endothelin, hypertension and chronic kidney disease: new insights","volume":"19","author":"Kohan","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.phrs.2010.12.008_bib0750","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/01.CIR.101.25.2922","article-title":"Study I. Acute endothelin a receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure","volume":"101","author":"Givertz","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2010.12.008_bib0755","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/01.HYP.25.4.883","article-title":"Endothelin antagonists improve renal-function in spontaneously hypertensive rats","volume":"25","author":"Kato","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2010.12.008_bib0760","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1097\/00005344-199322008-00084","article-title":"Antihypertensive effects of the endothelin receptor antagonist bq-123 in conscious spontaneously hypertensive rats","volume":"22","author":"Ohlstein","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0765","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.CIR.102.4.411","article-title":"Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension","volume":"102","author":"Williamson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2010.12.008_bib0770","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1152\/jappl.1995.79.6.2122","article-title":"Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats","volume":"79","author":"Chen","year":"1995","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0775","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (early study): a double-blind, randomised controlled trial [see comment]","volume":"371","author":"Galie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2010.12.008_bib0780","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11906-000-0064-5","article-title":"Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics","volume":"2","author":"Barton","year":"2000","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.phrs.2010.12.008_bib0785","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.CIR.97.8.752","article-title":"Endothelin-a receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-b receptor blockade","volume":"97","author":"Verhaar","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2010.12.008_bib0790","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neurobiolaging.2005.02.012","article-title":"Bosentan preserves endothelial function in mice overexpressing app","volume":"27","author":"Elesber","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.phrs.2010.12.008_bib0795","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2362.2009.02120.x","article-title":"The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies","volume":"39","author":"Davie","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.phrs.2010.12.008_bib0800","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/mp.2008.96","article-title":"Clearance mechanisms of alzheimer's amyloid-\u03b2 peptide: implications for therapeutic design and diagnostic tests","volume":"14","author":"Bates","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.phrs.2010.12.008_bib0805","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2174\/156720508783954785","article-title":"Amyloid-degrading enzymes as therapeutic targets in alzheimer's disease","volume":"5","author":"Nalivaeva","year":"2008","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.phrs.2010.12.008_bib0810","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/mt.2008.148","article-title":"Adeno-associated viral (aav) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces a beta deposits in app+ps1 transgenic mice","volume":"16","author":"Carty","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.phrs.2010.12.008_bib0815","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1582-4934.2010.01038.x","article-title":"Gene therapy in alzheimer's disease \u2013 potential for disease modification","volume":"14","author":"Nilsson","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.phrs.2010.12.008_bib0820","doi-asserted-by":"crossref","first-page":"7655","DOI":"10.1523\/JNEUROSCI.17-20-07655.1997","article-title":"Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein","volume":"17","author":"Zhang","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.phrs.2010.12.008_bib0825","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1161\/01.STR.0000024523.82311.77","article-title":"Cerebral hypoperfusion generates cortical watershed microinfarcts in alzheimer disease","volume":"33","author":"Suter","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2010.12.008_bib0830","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.phrs.2010.12.008_bib0835","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1113\/expphysiol.2008.043455","article-title":"Harvey cushing and the regulation of blood pressure in giraffe, rat and man: introducing \u2018cushing's mechanism\u2019","volume":"94","author":"Paton","year":"2009","journal-title":"Exp Physiol"},{"key":"10.1016\/j.phrs.2010.12.008_bib0840","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11906-007-0043-1","article-title":"Vascular-brain signaling in hypertension: role of angiotensin ii and nitric oxide","volume":"9","author":"Paton","year":"2007","journal-title":"Curr Hypertens Rep"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661810002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661810002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T10:24:27Z","timestamp":1559903067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661810002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":168,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1043661810002331"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2010.12.008","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}